Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocyte progenitor cells; strongest in cone photoreceptor cells | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 36 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 9576
Sealed predictions
- RCBTB1 in dopamine neurons, braak+0.00 (p 1.000) → -0.61 (p 0.078)receipt 9585
- RCBTB1 in oligodendrocytes, braak+0.41 (p 0.273) → +0.03 (p 0.946)receipt 9584
Swarm cases
receipt 9585: RCBTB1 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.173, n 18), 95% CI -0.69 to +0.16. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.32 (p 0.201, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.36 (p 0.137, n 18). could be the mix.
- skeptic
- leave-one-out range -0.44 to -0.26, sign flips 0; without severely affected donors -0.34 (p 0.173, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RCBTB1 in dopamine neurons.
case closed: nothing better to follow up.
receipt 9584: RCBTB1 in oligodendrocytes, braak
- power
- full sample +0.21 (p 0.413, n 18), 95% CI -0.29 to +0.61. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.355, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.34 (p 0.167, n 18). could be the mix.
- skeptic
- leave-one-out range +0.11 to +0.38, sign flips 0; without severely affected donors +0.21 (p 0.413, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RCBTB1 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts